Royal Bank of Canada’s Edesa Biotech EDSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15K | Buy |
1,851
+192
| +12% | +$1.73K | ﹤0.01% | 6466 |
|
|
2026
Q1 | $9K | Hold |
1,659
| – | – | ﹤0.01% | 6192 |
|
|
2025
Q4 | $2K | Sell |
1,659
-157
| -9% | -$307 | ﹤0.01% | 6895 |
|
|
2025
Q3 | $4K | Hold |
1,816
| – | – | ﹤0.01% | 6744 |
|
|
2025
Q2 | $4K | Hold |
1,816
| – | – | ﹤0.01% | 6678 |
|
|
2025
Q1 | $4K | Hold |
1,816
| – | – | ﹤0.01% | 6399 |
|
|
2024
Q4 | $3K | Buy |
1,816
+79
| +5% | +$220 | ﹤0.01% | 6635 |
|
|
2024
Q3 | $8K | Hold |
1,737
| – | – | ﹤0.01% | 6394 |
|
|
2024
Q2 | $7K | Hold |
1,737
| – | – | ﹤0.01% | 6441 |
|
|
2024
Q1 | $7K | Buy |
1,737
+1,520
| +700% | +$7.08K | ﹤0.01% | 6322 |
|
|
2023
Q4 | $1K | Buy |
217
+21
| +11% | +$80 | ﹤0.01% | 6914 |
|
|
2023
Q3 | $1K | Hold |
196
| – | – | ﹤0.01% | 6879 |
|
|
2023
Q2 | $1K | Hold |
196
| – | – | ﹤0.01% | 6989 |
|
|
2023
Q1 | $1K | Sell |
196
-8
| -4% | -$84 | ﹤0.01% | 6876 |
|
|
2022
Q4 | $3K | Hold |
204
| – | – | ﹤0.01% | 6848 |
|
|
2022
Q3 | $1K | Hold |
204
| – | – | ﹤0.01% | 7171 |
|
|
2022
Q2 | $2K | Hold |
204
| – | – | ﹤0.01% | 6938 |
|
|
2022
Q1 | $4K | Sell |
204
-72
| -26% | -$2K | ﹤0.01% | 7310 |
|
|
2021
Q4 | $11K | Buy |
276
+72
| +35% | +$3.44K | ﹤0.01% | 7025 |
|
|
2021
Q3 | $11K | Buy |
204
+157
| +334% | +$6.11K | ﹤0.01% | 6931 |
|
|
2021
Q2 | $2K | Hold |
47
| – | – | ﹤0.01% | 7241 |
|
|
2021
Q1 | $2K | Buy |
47
+39
| +488% | +$1.57K | ﹤0.01% | 7229 |
|
|
2020
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 7109 |
|
|
2020
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 6693 |
|
|
2020
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 6683 |
|
|
2020
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 6742 |
|
|
2019
Q4 | $0 | Buy |
+8
| New | +$283 | ﹤0.01% | 6883 |
|
|
2019
Q3 | – | Sell |
-7
| Closed | – | – | 6790 |
|
|
2019
Q2 | $0 | Hold |
7
| – | – | ﹤0.01% | 6934 |
|
|
2019
Q1 | $0 | Hold |
7
| – | – | ﹤0.01% | 6876 |
|
|
2018
Q4 | $0 | Hold |
7
| – | – | ﹤0.01% | 6835 |
|
|
2018
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 6774 |
|
|
2018
Q2 | $1K | Hold |
7
| – | – | ﹤0.01% | 6344 |
|
|
2018
Q1 | $2K | Hold |
7
| – | – | ﹤0.01% | 6105 |
|
|
2017
Q4 | $2K | Hold |
7
| – | – | ﹤0.01% | 6263 |
|
|
2017
Q3 | $2K | Buy |
+7
| New | +$2.55K | ﹤0.01% | 6555 |
|
|
2017
Q1 | – | Sell |
-3
| Closed | -$2K | – | 6642 |
|
|
2016
Q4 | $2K | Buy |
+3
| New | +$1.85K | ﹤0.01% | 6470 |
|
|
2016
Q3 | – | Sell |
-3
| Closed | -$4K | – | 6428 |
|
|
2016
Q2 | $4K | Sell |
3
-1
| -25% | -$1.03K | ﹤0.01% | 6001 |
|
|
2016
Q1 | $5K | Buy |
+4
| New | +$7K | ﹤0.01% | 5917 |
|
Other funds holding EDSA
VCIM
RCMNY
PA
SCM
BCM
Royal Bank of Canada's EDSA Position: Q2 2026 in Review
Royal Bank of Canada increased its Edesa Biotech (EDSA) stake by 12% in Q2 2026, buying an estimated $1.73K and bringing the position to 1,851 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #6466.
Royal Bank of Canada first reported a position in EDSA in Q1 2016 and has held it in 38 quarters since. 33 funds tracked by Wall St. Rank hold EDSA as of Q2 2026.
- Royal Bank of Canada held 1,851 shares of Edesa Biotech worth $15K as of Q2 2026.
- Royal Bank of Canada bought 192 Edesa Biotech shares in Q2 2026, an estimated $1.73K.
- Edesa Biotech made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #6466 holding.
- Royal Bank of Canada first reported a position in Edesa Biotech in Q1 2016 and has held it in 38 quarters since.
- 33 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.